Abstract:This paper describes a novel monoclonal antibody (C1G5F2) derived from mice splenocytes immunized in vitro with a wheat germ agglutinin glycoprotein fraction isolated from bovine central nervous system (CNS) myelin. Immunohistochemical reactions with C1G5F2 were investigated on rat brain sections during the active period of myelination. From day 10 to 13 postnatally, no stained structures were observed throughout the whole brain. The first immunolabeled myelin fibers were detected within the pons at day 14, and the white matter areas in the cerebrum started to be stained some days later. White matter areas of the cerebellum were clearly immunopositive after the third week. There was a strong positive signal on myelin fibers in the cerebrum at day 30. By contrast, no immunolabeled cell bodies of oligodendrocytes were observed throughout the brain. The other neural cell types were also not labeled. This C1G5F2 monoclonal antibody bound mainly to the extracytosolic membrane surface of the processes of live cultured oligodendrocytes derived from newborn rat brain but was unreactive with live or fixed astrocytes and neurons maintained in culture. No immunostaining was detected in the peripheral nervous system or in the spleen, liver, or pancreas. The C1G5F2 epitope containing antigen may therefore be considered as a CNS myelin/oligodendrocyte specific molecule. Sodium deoxycholate-Tween 20 extracts of secondary oligodendrocyte cultures, biotinylated with biotin hydrazide, were used to attempt the purification of the antigen with C1G5F2 IgMs linked to antimouse IgM agarose. A main broad biotinylated protein band of 54-58 kDa molecular mass was noted. In a second approach, the antigen was immunopurified from cultured oligodendrocytes as an immune complex using biotinylated C1G5F2 IgMs. A distinct protein doublet of 53-56 kDa was also observed. It is postulated that this antigen may play an essential role in myelin formation and could be a possible target in diseases restricted to CNS myelin.

Existence of NEU1 sialidase on mouse thymocytes whose natural substrate is CD5

Lysosomal sialidase NEU1, its intracellular properties, deficiency, and use as a therapeutic agent

NEU1 and NEU3 Sialidase Activity Expressed in Human Lung Microvascular Endothelia

Human Airway Epithelia Express Catalytically Active NEU3 Sialidase.

New Insights into Molecular Organization of Human Neuraminidase-1: Transmembrane Topology and Dimerization Ability

Identifying selective inhibitors against the human cytosolic sialidase NEU2 by substrate specificity studies.

Sialidase Occurs in Both Membranes of the Nuclear Envelope and Hydrolyzes Endogenous GD1a

Progress of Neu1 and Related Signaling Pathway

Neuraminidase-1: A Sialidase Involved in the Development of Cancers and Metabolic Diseases

NEU1 Sialidase Expressed in Human Airway Epithelia Regulates Epidermal Growth Factor Receptor (EGFR) and MUC1 Protein Signaling

Severe kidney dysfunction in sialidosis mice reveals an essential role for neuraminidase 1 in reabsorption

Implication of N-glycolylneuraminic acid in regulation of cell adhesiveness of C2C12 myoblast cells during differentiation into myotube cells

Neuraminidase-1 (NEU1): Biological Roles and Therapeutic Relevance in Human Disease

Defect in cytosolic Neu2 sialidase abrogates lipid metabolism and impairs muscle function in vivo

Immunologic Glycosphingolipidomics And Nkt Cell Development In Mouse Thymus

Cutting Edge: Impaired Glycosphingolipid Trafficking and NKT Cell Development in Mice Lacking Niemann-Pick Type C1 Protein

Identification and Functional Characterization of a New Gene Encoding the Mouse Terminal Complement Inhibitor CD59

Secondary deficiency of neuraminidase 1 contributes to CNS pathology in neurological mucopolysaccharidoses via hypersialylation of brain glycoproteins

S1p(1) Receptor Expression Regulates Emergence of Nkt Cells in Peripheral Tissues

Identification of a novel human UDP-GalNAc transferase with unique catalytic activity and expression profile

A new oligodendrocyte specific plasma membrane surface protein identified by a monoclonal antibody produced in vitro